MICHAEL D. CASEY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Capstone Holding Corp.

Filing Date Source Excerpt
2004-04-29 Michael D. Casey, 58, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc., a publicly traded cancer therapy company until it was acquired by Chiron Corporation in March 2002.
2005-03-07 Michael D. Casey, 59, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc., a publicly traded cancer therapy company until it was acquired by Chiron Corporation in March 2002.
2006-04-14 Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc.
2007-04-09 Michael D. Casey, 61, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey informed the OrthoLogic Board of Directors on March 28, 2007, that he does not intend to seek re-election to the Board at the Annual Meeting of Stockholders on May 10, 2007 due to personal and family commitments.

DURECT CORP

Filing Date Source Excerpt
2006-04-27 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various executive roles in pharmaceutical companies.
2007-04-30 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various positions at Johnson & Johnson companies.
2008-04-29 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various executive roles in pharmaceutical companies.
2009-04-29 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc.
2010-04-29 Mr. Casey's executive leadership experience with pharmaceutical companies and his expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications he brings to the Board and his service as a Director of the Company.
2011-04-28 Mr. Casey’s executive leadership experience with pharmaceutical companies and his expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications he brings to the Board and his service as a Director of the Company.
2012-04-26 Mr. Casey was Chairman, President and CEO of Matrix Pharmaceuticals and held various executive roles in pharmaceutical companies.
2013-04-29 Mr. Casey was Chairman, President and CEO of Matrix Pharmaceuticals and has executive leadership experience with pharmaceutical companies.

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-04 Michael D. Casey(4) 103,750 Fees Earned or Paid in Cash, 5,500 Stock Awards, 18,592 Option Awards, Total 127,842

Data sourced from SEC filings. Last updated: 2025-12-07